more_reports

Streetwise Articles



Gold Stock Looking Ready to Reverse to the Upside
Source: Clive Maund for Streetwise Reports  (7/7/21)
Technical analyst Clive Maund charts Sitka Gold and explains why he sees it as a speculative buy. More >


Peter Epstein

FenixOro Gold Undervalued, Trading at <1% of the Value of Nearby Buriticá Mine
Source: Peter Epstein for Streetwise Reports  (7/7/21)
Peter Epstein of Epstein Research explains why he believes FenixOro "offers a compelling high-risk/high-reward investment proposition." More >


Biohaven Posts Revenue of $93 Million in Q2 for Its Migraine Medicine
Source: Streetwise Reports  (7/7/21)
Shares of Biohaven Pharmaceutical Holding Co. Ltd. traded 12% higher to a new 52-week high after the company reported preliminary Q2/21 net product revenue of $93 million for NURTEC ODT, which it claims is the first and only FDA approved medicine for both acute and preventive migraine treatment. More >


Technical Analyst Sees Bullish Signal for Mining Junior
Source: Clive Maund for Streetwise Reports  (7/7/21)
Technical analyst Clive Maund explains why he has a Buy recommendation for Barsele Minerals. More >


Helium Exploration & Development Company Offers 'Key Advantages'
Source: Streetwise Reports  (7/6/21)
An Eight Capital initiation report details the factors that make Imperial Helium attractive. More >


Positive Project PEA Makes Uranium Company 'Two Trick Pony,' Says Analyst
Source: Streetwise Reports  (7/6/21)
The preliminary economic assessment for Azarga Uranium's Gas Hills project and what it means for the company are discussed in a Haywood Securities report. More >


Nevada Gold Explorer Discusses High-Grade Drill Results
Source: Streetwise Reports  (7/6/21)
Riley Gold, operating in the "best jurisdiction in the world," according to the Fraser Institute, is turning heads with the drill bit.







More >


ALX Oncology Shares Rise on Positive Response and Survival Data in Phase 1b Gastric Cancer Trial
Source: Streetwise Reports  (7/6/21)
Shares of ALX Oncology Holdings Inc. traded 10% higher after the company reported new data from its Phase 1b ASPEN-01 study of ALX148 demonstrated a robust objective response in patients with gastric or gastroesophageal junction cancer. More >


Peter Krauth

The Silver Bull Is Not Transitory
Source: Peter Krauth for Streetwise Reports  (7/6/21)
Peter Krauth of Silver Stock Investor delves into the silver market and discusses why it "looks primed to rally strongly on the back of multiple drivers." More >


Maurice Jackson

Mexican Gold Producer Moves Ahead with Multiple Prospects
Source: Maurice Jackson for Streetwise Reports  (7/5/21)
Maurice Jackson of Proven and Probable discussed the latest news out of Magna Gold with the company's CEO, Arturo Bonillas. More >


 McAlinden Research Partners

Long-Term Rise in Electric Vehicle Sales Likely to be Driven by a Buildout of Charging Infrastructure
Source: McAlinden Research for Streetwise Reports  (7/5/21)
McAlinden Research Partners concludes that the investment in charging station infrastructure must rise in order to meet the push from automakers and governments for increasing electric mobility. More >


Alector Partners with GSK to Develop Monoclonal Antibodies for Neurodegenerative Diseases
Source: Streetwise Reports  (7/2/21)
Alector Inc. shares traded 59% higher after the company announced it entered into a global collaboration agreement with GlaxoSmithKline to develop and advance two first-in-class, clinical stage monoclonal antibodies for treating neurodegenerative diseases including frontotemporal dementia, amyotrophic lateral sclerosis, Parkinson's and Alzheimer's. More >


Explorer's Drilling in Nevada 'Returns Shallow High Grades and Shows Lateral Continuity'
Source: Streetwise Reports  (7/1/21)
Initial results from Riley Gold's maiden drilling and additional sampling at Tokop are presented in a Haywood Securities report. More >


Uranium Firm's PEA Calls for 6.5 Mlb of U3O8 Production Over 7 Years at Wyoming Project
Source: Streetwise Reports  (7/1/21)
Azarga Uranium Corp. reported details from the maiden Preliminary Economic Assessment for its Gas Hills ISR Uranium Project that project annual production volumes of 1.0 Mlb of U3O8 over an estimated 7-year mine-life. More >


Analysts: 'Precious Metals Outlook Remains Attractive'
Source: Streetwise Reports  (7/1/21)
CIBC discusses in a report its current expectations for gold and silver, its revised price deck for both metals and why it believes now is a good time to invest in stocks in the space. More >


Company Changes Name to Reflect Expanded Focus on Gold and Copper Exploration
Source: Streetwise Reports  (7/1/21)
First Vanadium Corp. reported it is changing its name to Phenom Resources Corp. as it is now actively engaged in gold and copper exploration in addition to vanadium. More >


Diversified Mineral Explorer Secures DTC Eligibility for Electronic Trading in the US
Source: Streetwise Reports  (7/1/21)
Group Ten Metals reported that the Depository Trust Company has approved its shares for electronic clearing and settlement in the United States. More >


Pulse Bio Shares Beat Higher on Launch of CellFX NPS System in Canada
Source: Streetwise Reports  (7/1/21)
Pulse Biosciences shares traded 27% higher after the company announced it secured a $50 million private placement one day after it reported the first CellFX® procedure using its proprietary Nano-Pulse Stimulation technology had been performed in Canada. More >


Coverage Initiated on Developer of Psychedelic Drugs for PTSD, Smoking Cessation
Source: Streetwise Reports  (6/30/21)
The investment thesis for Mydecine Innovations Group is presented in a ROTH Capital Partners report. More >


Diverse Pipeline for Repurposing Drug Company Includes Treatments for Idiopathic Pulmonary Fibrosis and Chronic Cough, Pancreatic Cancer and Stroke
Source: Streetwise Reports  (6/30/21)
Repurposing extends a drug's reach and value, and Algernon Pharmaceuticals' strategy of finding and demonstrating new uses for existing drugs reduces risk, accelerates time to market and increases capital efficiency. More >


Biotech Takes a 'Disruptive Drug Development Approach' to Destroy Dysregulated Transcription in Cancer
Source: Streetwise Reports  (6/30/21)
Kronos Bio's key assets are reviewed in an H.C. Wainwright & Co. report. More >


Vertex Energy Shares Rise 36% on Sale of Oil Collection and Recycling Portfolio
Source: Streetwise Reports  (6/30/21)
Vertex Energy shares climbed to a new 52-week high after the company reported it entered into an agreement to sell its used motor oil collection and recycling assets to Safety-Kleen Systems for $140 million. More >


Maurice Jackson

'Most Prolific Royalty Generator on the Planet' Provides Optionality
Source: Maurice Jackson for Streetwise Reports  (6/30/21)
David Cole, the CEO of EMX Royalty, talks to Maurice Jackson of Proven and Probable about recent developments at several properties where the firm owns royalties. More >


Helium Company 'Continues to Stand Out as a Leader in the North American Helium Pubco Space'
Source: Streetwise Reports  (6/29/21)
Royal Helium's recent financing, its path to first production and its resource growth plan are all discussed in a Cormark Securities report. More >


Small-Cap Firm's AI Technology Finds a Large Niche with the 'Underbanked'
Source: Streetwise Reports  (6/29/21)
Marble Financial is aggressively expanding its groundbreaking programs for the financially underserved, with plans for hockey stick growth from the current 20,000 users to 100,000 by year-end, and 1 million users in 2022. More >


Showing Results: 6601 to 6625 of 26559 Prev Next

Notable Quotes

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe